approaches to and the use of mrd in all
Published 1 year ago • 414 plays • Length 5:17Download video MP4
Download video MP3
Similar videos
-
0:46
the importance of mrd assessment in all phases of all treatment
-
1:10
the challenge of persistent mrd in t-all & novel approaches being explored
-
1:32
methods to evaluate mrd in aml
-
1:46
importance of mrd monitoring in all
-
0:36
mrd studies in all and aml
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
8:53
how is mrd testing done?
-
1:01:40
measurable residual disease by multiparametric flow cytometry in acute lymphoblastic leukemia
-
2:07
using mrd to improve patient outcomes
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
1:22
methods to measure mrd & its role in predicting patient outcomes in aml
-
3:01
minimal residual disease: a key determinant of all treatment response
-
1:46
the importance of mrd monitoring in aml
-
1:26
mrd in myeloma: the fda perspective
-
0:41
mrd measurement: next-generation sequencing or flow cytometry?
-
1:23
the role of mrd status & the eln 2022 in predicting clinical outcomes of patients with aml
-
2:40
integrated approaches to the diagnosis of mds & mpns
-
2:31
mrd-oriented trials for patients with relapsed t-all
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
3:05
mrd negativity assessed by flow cytometry associated with improved outcomes in npm1-mutated aml
-
8:42
assessing mrd in multiple myeloma
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study